BeiGene, Ltd.
BTK inhibitors with improved dual selectivity
Last updated:
Abstract:
Disclosed herein is a tri-substituted phenyl Btk inhibitors with improved dual selectivity, a method and a composition for inhibiting Btk and treating disease associated with undesirable Btk activity (Btk-related diseases).
Status:
Grant
Type:
Utility
Filling date:
12 Aug 2018
Issue date:
5 Jul 2022